Company / Shareholders' Equity
BICYCLE THERAPEUTICS PLC Shareholders' Equity History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$610.0M
FY2025
5-year range
$93.2M / $793.1M
FY2021-FY2025
Trend
-23.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $371M to $610M over the past 2 years.
Based on SEC 10-K filings.
$610M in FY2025 with a 3-year CAGR of +85.6%.
Improved from $371M to $610M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +85.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +85.6%, indicating consistent growth.
- In FY2025, shareholders' equity decreased 23.1% year-over-year.
- Peak shareholders' equity was recorded in FY2024.
- Lowest shareholders' equity in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.98 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $610.0M | -23.1% |
| FY2024 | $793.1M | +113.8% |
| FY2023 | $370.9M | +288.6% |
| FY2022 | $95.5M | +2.4% |
| FY2021 | $93.2M | +233.5% |
| FY2020 | -$69.8M | -48.0% |
| FY2019 | -$47.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026